Really impressive - especially considering that the luminal b type breast cancer has so few treatment options and such a tough prognosis. Roughly 25% of all mBC is luminal so my guess is that we'll see MRK move pretty fast now that they've got their new cancer trials network in place to run trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.